prostatic neoplasms/phosphatase

Länken sparas på Urklipp

Välj sorteringstyp

Sida 1 från 635 resultat

Diagnostic value of prostatic acid phosphatase and prostate-specific antigen in patients with prostatic cancer.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

To compare the clinical usefulness of the measurement of prostatic acid phosphatase (PAP) and prostate-specific antigen (PSA) in serum of patients with prostatic carcinoma, we studied 128 patients with prostatic pathology, sixty (46.9%) of whom had prostatic cancer. Receiver-operating

Extremely high concentration of serum prostate-specific acid phosphatase in an untreated prostatic cancer patient.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

We report a patient having advanced prostatic cancer and serum immunoreactive prostate-specific acid phosphatase concentrations of up to 8.9 mg/l, which is more than 3000 times the upper limit of our health-associated reference interval. following orchiectomy, the enzyme concentration decreased to

[Diagnostic value of prostatic specific antigen (PSA) in comparison to prostatic acid phosphatase (PAP) in prostatic cancer and adenoma].

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

The diagnostic value of the tumour markers: PSA, PAP and AcP was studied before treatment in 379 men (47 with prostatic cancer--PC, 306 with benign hyperplasia--PBH, and 26 healthy subjects--control group CG). PSA was determined by the enzymoimmune method, and the phosphatases were evaluated by the

Serum and bone marrow radioimmunoassay of acid phosphatase in prostatic cancer.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Use of radioimmunoassay (RIA) for determinations of prostatic acid phosphatase has recently received considerable attention because of reported higher sensitivity and specificity than previous enzymatic assays. We have compared the sensitivity and specificity of a commercially available RIA to a

Radioimmunodetection of lymph node invasion in prostatic cancer. The use of iodine 123 (123I)-labeled monoclonal anti-prostatic acid phosphatase (PAP) 227 A F(ab')2 antibody fragments in vivo.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

The therapeutic indications in prostatic cancer depend on the regional and distant extension of the cancer and are difficult to assess before lymphadenectomy. Radioimmunodetection of lymph node involvement with monoclonal anti-prostatic acid phosphatase (PAP) antibodies can be proposed as a

Lack of value of radioimmunoassay for prostatic acid phosphatase as a screening test for prostatic cancer in patients with obstructive prostatic hyperplasia.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

We examined the incidence of prostatic cancer in patients with an elevated radioimmunoassay for prostatic acid phosphatase and clinical benign prostatic hyperplasia on digital rectal examination. Of 295 patients screened with prostatic acid phosphatase tests 17 fulfilled the criteria of having an

Differential sensitivity of human prostatic cancer cell lines to the effects of protein kinase and phosphatase inhibitors.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

We investigated the effect of protein kinase and phosphatase inhibitors on the growth of six human prostatic cancer cell lines: DU145, PC3, ND1, LNCaP, ALVA31 and JCA1. We studied okadaic acid and sodium orthovanadate as serine/threonine and tyrosine protein phosphatase inhibitors, respectively, and

Prostatic acid phosphatase in serum of patients with prostatic cancer is a specific phosphotyrosine acid phosphatase.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

We developed an assay to measure at acid pH the phosphotyrosine phosphatase activity in sera from patients with prostatic cancer. The method used quantifies the inorganic phosphate liberated from phosphotyrosine after incubation with serum, followed by the deproteinization of the reaction mixture. A

Immunoreactive prostatic acid phosphatase in prostatic cancer: diagnosis and followup of patients.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

We compared the measurements of serum acid phosphatase activity to those obtained by radioimmunoassay of prostatic acid phosphatase in the sera of 126 untreated prostatic cancer patients. The catalytic activity of prostatic acid phosphatase was elevated in 32 per cent of the patients and the serum

Unpredictable fluctuations in serum acid phosphatase activity in prostatic cancer.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Repeated determinations of the elevated serum acid phosphatase activities in five patients with advanced prostatic cancer were found to be highly variable during 24 to 48 hours of observation. Samples collected every three hours had fluctuations of 44% to 97% around the 24- to 48-hour mean values.

Prostatic cancer, acid phosphatase, creatine kinase-BB and race: a prospective study.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

To examine the effectiveness of prostatic acid phosphatase and creatine kinase-BB determinations in detecting prostatic cancer serum from 594 men more than 40 years was assayed for prostatic acid phosphatase with the thymolphthalein monophosphate substrate and a radioimmunoassay kit. Creatine

Review of acid phosphatase in the diagnosis and prognosis of prostatic cancers.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Acid phosphatase is a secretory product frequently utilized as a tumor marker for disseminated, late stage (D2) prostatic cancer. In the 40 years since this association has been recognized, this enzyme has been subjected to extensive biochemical and immunological characterizations. These techniques

[Improved diagnostic evaluation of prostatic neoplasms using radioimmunoassay for prostatic acid phosphatase].

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Better diagnosis of prostatic cancer by RIA of serum prostatic acid phosphatase? The results of serum determination of RIA prostatic acid phosphatase (PAP) and enzymatic serum phosphatase were compared in 267 patients with the clinical diagnosis to reveal the diagnostic value of the RIA-PAP in

Comparative evaluation of serum acid phosphatase, urinary cholesterol, and androgens in diagnosis of prostatic cancer.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Serum acid phosphatase activity, urinary total cholesterol, and ratio of deoxy to oxy urinary 17-ketosteroids were measured in a group of 42 patients with prostatic carcinoma and in a group of 14 age-matched normal healthy individuals. Our purpose was to evaluate whether or not the simultaneous

Radioimmunoassay for prostatic acid phosphatase helps discriminate patients with prostatic cancer.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

We measured serum prostatic acid phosphatase in ostensibly normal controls and a selected patient population, using both a modified radioimmunoassay and an enzymic method with thymolphthalein monophosphate as substrate. The upper limit of normal for the radioimmunoassay was 2.2 micrograms/L; its

Tidigare
1
2
3
4
5
6
...
42
43
Nästa

Gå med på vår
facebook-sida

Herbal & Natural Medicine

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen

Fungerar på 55 språk
Växtbaserade botemedel som stöds av vetenskap
Örter igenkänning av bild
Interaktiv GPS-karta - märka örter på plats (kommer snart)
Läs vetenskapliga publikationer relaterade till din sökning
Sök efter medicinska örter efter deras effekter
Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent

Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning